Anupam Rasayan India Ltd. has achieved a significant milestone by becoming the first company globally to commercialize ETFA (Ethyl trifluoroacetate) using its proprietary continuous flow chemistry platform. This innovative process offers enhanced safety, efficiency, and sustainability, positioning the company as a leader in complex fluorination chemistry and addressing the growing demand for ETFA in the life sciences and pharmaceutical sectors. The global market for ETFA is estimated at USD 500-600 million.
Global First in Specialty Chemical Production
Anupam Rasayan India Ltd. (NSE: ANURAS, BSE: 543275) has announced a groundbreaking achievement: it is now the first company in the world to commercialize ETFA (Ethyl trifluoroacetate) production utilizing its proprietary process-by-design continuous flow chemistry platform. This marks a significant advancement in the specialty chemicals sector, particularly in the domain of complex fluorination chemistry.
About ETFA and Its Applications
ETFA is identified as a critical fluorinated building block and reagent essential for synthesizing a wide array of organic fluorine compounds. These compounds are integral to advancements across the life sciences, pharmaceutical, and performance materials industries, where fluorine chemistry plays a crucial role in enhancing product performance, efficacy, and stability. The global addressable market for ETFA is substantial, estimated at approximately USD 500-600 million, underscoring its strategic importance within the specialty chemicals value chain.
Advantages of the Flow Chemistry Platform
The company’s achievement positions it as a global leader in manufacturing ETFA at a commercial scale using flow technology. Compared to conventional batch processes, the continuous flow platform presents numerous advantages. These include significantly enhanced process safety, superior reproducibility, improved scalability, higher operational efficiency, and a lower environmental footprint. This innovative approach aligns with the growing industry focus on sustainable and efficient manufacturing practices.
Leadership Vision and Future Strategy
Anand Desai, Managing Director of Anupam Rasayan, commented on the achievement, stating, “The successful commercialisation of ETFA through our continuous flow chemistry platform represents a significant milestone in Anupam Rasayan’s innovation journey. This achievement not only demonstrates our technological capabilities in complex fluorination chemistry but also highlights our ability to develop and scale differentiated manufacturing solutions that address evolving customer requirements.” He further emphasized that innovation remains at the core of the company’s growth strategy, with continued investment in cutting-edge process technologies, research capabilities, and sustainable manufacturing practices to create long-term value.
Anupam Rasayan India Ltd. Overview
Anupam Rasayan India Ltd. is recognized as a leading player in custom synthesis (CSM) and the manufacturing of specialty chemicals in India. Established in 1984, the company operates across two key verticals: Life Science related Specialty Chemicals (including Agrochemicals, Personal Care, and Pharmaceuticals) and Performance Materials (comprising Electronics & EV Chemicals and Polymers). Anupam serves a diverse client base of over 75 domestic and international customers, including 31 multinational corporations. The company operates eight manufacturing facilities across India and the USA, with an aggregate installed capacity of approximately 66,000 MT as of March 31, 2026.
Product Launch Details
The product, ETFA (Ethyl trifluoroacetate), was officially launched on June 11, 2026, and is classified as a Chemical Intermediate. The company caters to both domestic and international markets, with the product being launched in multiple countries including the USA and Japan, among others.
Source: BSE
